Clinical outcomes of withdrawing one medication from long-term combination therapy comprising α-blocker and 5α-reductase inhibitor for benign prostatic hyperplasia-Reference-Cited by-同舟云学术

Clinical outcomes of withdrawing one medication from long-term combination therapy comprising α-blocker and 5α-reductase inhibitor for benign prostatic hyperplasia

Published:2023-02-10 Issue: Volume: Page:
ISSN:1573-2584
Container-title:International Urology and Nephrology
language:en
Short-container-title:Int Urol Nephrol

Author:

Choi Jae Duck^ORCID,Yoo Tag Keun^ORCID,Kang Jung Yoon^ORCID,Jung Hyuk-Dal^ORCID,Lee Jun Ho^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Urology,Nephrology

Link

https://link.springer.com/content/pdf/10.1007/s11255-023-03476-6.pdf

Reference22 articles.

1. Emberton M, Andriole GL, de la Rosette J, Djavan B, Hoefner K, Vela Navarrete R, Nordling J, Roehrborn C, Schulman C, Teillac P, Tubaro A, Nickel JC (2003) Benign prostatic hyperplasia: a progressive disease of aging men. Urology 61(2):267–273. https://doi.org/10.1016/s0090-4295(02)02371-3

2. Jacobsen SJ, Jacobson DJ, Girman CJ, Roberts RO, Rhodes T, Guess HA, Lieber MM (1997) Natural history of prostatism: risk factors for acute urinary retention. J Urol 158(2):481–487. https://doi.org/10.1016/s0022-5347(01)64508-7

3. Marks LS, Andriole GL, Fitzpatrick JM, Schulman CC, Roehrborn CG (2006) The interpretation of serum prostate specific antigen in men receiving 5alpha-reductase inhibitors: a review and clinical recommendations. J Urol 176(3):868–874. https://doi.org/10.1016/j.juro.2006.04.024

4. Madersbacher S, Marszalek M, Lackner J, Berger P, Schatzl G (2007) The long-term outcome of medical therapy for BPH. Eur Urol 51(6):1522–1533. https://doi.org/10.1016/j.eururo.2007.03.034

5. Fourcade RO, Lacoin F, Rouprêt M, Slama A, Le Fur C, Michel E, Sitbon A, Cotté FE (2012) Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia. World J Urol 30(3):419–426. https://doi.org/10.1007/s00345-011-0756-2